.

OracleBio & Lumito Launch Tissue Imaging Pilot
2 April 2026
By Mark Laurie

OracleBio is pleased to announce the initiation of a joint pilot project with Lumito AB, a specialist in high-sensitivity digital tissue imaging technology.

The project will explore the combination of Lumito’s innovative tissue labelling and imaging platform with OracleBio’s expertise in quantitative digital pathology image analysis. Together, the two companies will evaluate potential synergies and the value of an integrated solution, supported by an external scientific expert in pathology.

The collaboration reflects the growing demand OracleBio is seeing from Pharma clients for more detailed histological profiling of novel therapeutic targets at the tissue, cell and cell compartment level.

“Combining our image analysis expertise with high quality histological staining and imaging techniques enables us to provide an optimal service to our clients. By collaborating with Lumito, we gain the opportunity to work with an innovative tissue imaging technology and look forward to jointly evaluating potential applications.” – Lorcan Sherry, Chief Scientific Officer, OracleBio

Read the full press release here.

📩 Newsletter: Subscribe now for the latest Webinars, Videos, Articles & more! →

Find out about OracleBio's Pathology Expertise

Learn How OracleBio Can Support You

Speak to our experts

Planning your study and need advice on your image analysis? We’d love to chat!